161 Development of a CD8 co-receptor independent T cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T cell-based immunotherapy by Daniel Sommermeyer, Christian Ellinger, Giulia Longinotti, Dolores Schendel, Kathrin Davari, Tristan Holland, Laura Prassmayer, Kenneth Ganley, Lisa Pechilis, Iulia Diaconu, Prashant Nambiar, Mike Magee, Rer Nat

T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and St... by Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde, Daniel Sommermeyer

Get full text

427 Development of iPSC-derived cytotoxic CD8+ T-cells as the basis for innovative off-the-shelf cancer immunotherapies by Daniel Sommermeyer, Chloé Beuraud, Monika Braun, Michael Epstein, Philip Hublitz, Michael Esquerré, Audrey Holtzinger, Nadja Wagner, Riga Tawo, Florie Bertrand, Olivia Cypris, Pauline Barron, Stefanie Pfänder, Stephanie Sontag

1515 Gene edited iPSC-derived macrophages (iMACs) show increased phagocytosis in pre-clinical tumor models by Daniel Sommermeyer, Monika Braun, Michael Epstein, Tanja Schneider, Kathrin Haake, Michela Mirenda, Quentin Bernard, Philip Hublitz, Lucie Gouxette, Martin Briscadieu, Philine Scheinpflug, Garima Singh, Alica Hinkelmann, Michael Esquerré, Audrey Holtzinger, Michael Paillasse, Andreas Scheel, Markus Dangl, Nadja Wagner